
Dimitrios P. Kontoyiannis MD ScD, PhD, FIDSA, FECMM, FAAM, FAAAS
Transplant/Immunocompromised States
Texas 4000 Distinguished Endowed Professor
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Kontoyiannis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), is the Robert C Hickey Chair in Clinical Care and Deputy Head for Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center. I received my medical degree Summa Cum Laude from the National and Kapodistrian University of Athens, Greece and trained in Internal Medicine at Baylor College of Medicine in Houston, TX, where I served as a Chief Medical Resident. I was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a Master in Clinical Sciences from Harvard Medical School in Boston and I spent 3 years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program. I am considered the leading expert in mycology world-wide (expertscape.com) and among the 1-2 most highly cited investigators in the area of mycology with over 600 peer-reviewed publications and 51000 citations and an H index of 111 (Google Scholar) and in the 1% list of most influential/cited researchers in the biomedical field (Web of Science). I have had a funded laboratory and clinical program in mycology in the last 22 years. I am the recipient of many institutional, national and international awards in research/clinical care, education and mentoring and I am fellow of many honorific societies(see CV). I would be interested to explore relevant and interesting leadership position in Internal Medicine, Infectious Diseases or academia (e.g., Chief of Medicine, Vice Provost, etc) in a prestigious academic center that capitalize of my 22 year multi-faceted and successful experience as a clinical research-oriented faculty at a tertiary care academic center.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1994 - 1998
Baylor College of MedicineResidency, Internal Medicine, 1991 - 1994
University of AthensClass of 1989
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 1998 - 2027
MA State Medical License 1994 - 1999
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013, 2015
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013, 2015
Publications & Presentations
PubMed
- Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis.Sebastian Wurster, Jezreel Pantaleon Garcia, Yongxing Wang, Nathaniel D Albert, Uddalak Bharadwaj
Proceedings of the National Academy of Sciences of the United States of America. 2026-05-26 - Fungal central nervous system infection caused by non-Candida yeasts and dimorphic fungi following neurosurgical procedures: Iatrogenic or not?Chia-Yu Chiu, Rachel S Hicklen, Dimitrios P Kontoyiannis
Medical Mycology. 2026-05-01 - Closing the gap on antifungal resistance.Paul E Verweij, Ana Alastruey-Izquierdo, Karin Amilon, Maiken Cavling Arendrup, Darius Armstrong-James
Nature Medicine. 2026-05-01
Journal Articles
- Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future DirectionsDimitrios Kontoyiannis, MD, Clinical Infectious Diseases
- Breakthrough Fungal Infections in Patients with Leukemia Receiving IsavuconazoleDimitrios Kontoyiannis, MD, Clinical Infectious Diseases
Press Mentions
Shop TalkJanuary 5th, 2018- Shop TalkJanuary 5th, 2018
Cidara Therapeutics’ Presentations at ASH 2016 to Highlight Potential Role of Novel Antifungal CD101 in Patients with Hematologic MalignanciesNovember 28th, 2016
Grant Support
- Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosisUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









